After a very profitable decade on Microsoft's board, Reid Hoffman is stepping down to focus on his AI drug discovery startup Manus.
This latest lawsuit is particularly broad and homes in on accusations of illegal piracy.
Investors, founders, and operators from across Europe arrived for the annual Nordic TechBBQ conference to talk about how humans can have agency over AI.
Vijay Pande — who left a16z's roughly $4 billion biotech practice last year to start the much smaller, AI-native VZVC — talks about why biology is finally shifting from a "discovery" science to an "engineering" one, why clinical trials are still brutally expensive, and why he thinks open, shared…
Several Hollywood celebs are ditching the massive eight-figure checks and exotic movie sets for a rising format: microdramas.